FRAXA Research Foundation
FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments.
Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders.
Fragile X Research Q&A: Dr. Berry-Kravis on the RECONNECT Trial
A Turning Point in Fragile X Research: Treatments and Curative Approaches
What’s New in Fragile X Research? 2025 FRAXA Grants & Live Q&A | June 2025 Webinar
Shionogi Shares Update on EXPERIENCE Trials for Fragile X
New Fragile X Clinical Trial: BK Channel Openers
World Fragile X Day 2024: A Global Celebration of Awareness and Research Progress
Understanding Anxiety in Fragile X Syndrome with Dr. Carrie Buchanan | July 2024 Webinar
Latest Fragile X Clinical Trial and Research Updates | May 2024 Webinar
Zatolmilast Phase 3 Clinical Trial in Fragile X Syndrome
Fragile X Research: Current Treatment Trials and Progress Towards a Cure - Q&A Webinar (Nov 2023)
Pioneering Community-Based Drug Development for Fragile X - FRAXA Research Foundation
Step Up for World Fragile X Day: Join Us in Making a Difference
Journey Through Fragile X Clinical Trials: Parents Share their Experiences
Collaborating to support the Rare Disease Community on Rare Disease Day
I Feel like I Found My Purpose and I Feel So Good about That
10 Year Vision for Fragile X Research - Dr. Elizabeth Berry-Kravis & Dr. Patricia Cogram
Meet the Murphys
A Note of Thanks and Hope on This #GivingTuesday
Sigma-1 Receptor as a Therapeutic Target for Fragile X Syndrome
If we could replace FMRP to treat Fragile X syndrome, which version would we use?
World Fragile X Day Is Lighting the Way for Fragile X!
Targeting Serotonin 1A Receptors in Fragile X
Fragile X Syndrome: Innovative Approaches to Finding a Cure
Kelly Coleman - FRAXA's Global Vision Award 2022
Dr. Kathryn Whitehead - FRAXA’s Ingenuity Award recipient
Jennifer Puett - FRAXA’s Global Vision Awards 2022
Why Pharma Companies Take on Fragile X, Explained
Shine a Light on Fragile X on World Fragile X Day
mRNA Therapy for Fragile X Syndrome